Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies, PreventionGenetics Settle Patent Infringement Lawsuit

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled a lawsuit it filed against PreventionGenetics late last year claiming patent infringement.

The two parties have also reached a licensing agreement, and GTG's lawsuit will be dismissed as a result. Terms of the settlement were not disclosed.

GTG sued Marshfield, Wis.-based PreventionGenetics in November alleging it infringed US Patent No. 5,612,179, which covers GTG's non-DNA coding technology. The patent is at the center of numerous patent infringement lawsuits filed by the Australian firm.

Earlier this month, the US Patent and Trademark Office granted a request from Merial for a second ex parte re-examination of the patent. In December, GTG settled with Roche 454 Life Sciences over the '179 patent. The two also reached a licensing agreement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.